Master in Pharmacoepi Pharmacovigilance London

Tuition comes to 5,390 GBP per year.

Graduates of this programme typically advance into pivotal roles within the pharmaceutical industry, government regulatory bodies, academic research institutions, and international NGOs. By bridging the gap between theoretical epidemiology and practical safety monitoring, the course prepares professionals to navigate the complex global landscape of drug safety, risk management, and health policy.

This intensive, modular Professional Certificate is specifically designed for those tasked with ensuring drug safety and evaluating the risks and benefits of pharmaceutical interventions. Whether you are working in drug development, licensing, or clinical surveillance, this programme provides the rigorous analytical framework required to make evidence-based decisions in a field where public confidence and patient health are paramount.

Distinctive Expertise

Delivered by the internationally renowned EHR Research Group at LSHTM, the curriculum is rooted in real-world data application. Participants benefit from:

• A blend of theoretical insight and practical methodology covering epidemiology, statistics, and health economics.
• Direct engagement with leading experts from regulatory bodies and industry who share current, actionable insights.
• A flexible, online learning environment that balances pre-recorded lectures with interactive, synchronous Q&A sessions.
• The opportunity to join a global alumni network spanning over 50 countries, facilitating professional connections across the public and private health sectors.